Xiangqian Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiangqian Jia has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Yanlong Zhang
Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education & Heilongjiang Provincial Key Laboratory of Ecological Restoration and Resource Utilization for Cold Region & Key Laboratory of Microbiology, College of Heilongjiang Province, School of Life Sciences, Heilongjiang University, Harbin 150080, China
4 shared publications - Juanjuan Du
Tsinghua University
2 shared publications Weimin Zeng
Heilongjiang Univ, Engn Res Ctr Agr Microbiol Technol, Minist Educ, Harbin 150080, Peoples R China
2 shared publicationsWenwen Yan
Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education & Heilongjiang Provincial Key Laboratory of Ecological Restoration and Resource Utilization for Cold Region & Key Laboratory of Microbiology, College of Heilongjiang Province & School of Life Sciences, Heilongjiang University, Harbin 150080, China
2 shared publicationsYadong Chen
Heilongjiang Univ, Engn Res Ctr Agr Microbiol Technol, Minist Educ, Harbin 150080, Peoples R China
2 shared publications- Yang Liu
Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education & Heilongjiang Provincial Key Laboratory of Ecological Restoration and Resource Utilization for Cold Region & Key Laboratory of Microbiology, College of Heilongjiang Province, School of Life Sciences, Heilongjiang University, Harbin 150080, China
2 shared publications
Latest Publications
- 24 August 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (35) , 24401-24414
Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity
Effective lung-targeted therapies can directly treat pulmonary diseases and engage tissue-resident immunity for lasting effects. However, protein delivery systems specifically targeting the lung remain scarce. Here, we report the discovery of phenylborate (PBA)-functionalized polymeric nanocapsules that enable efficient pulmonary delivery of protein cargos following systemic administration. Systematic structure–activity relationship studies revealed that PBA incorporation strongly correlates with enhanced lung tropism, establishing a previously unrecognized materials design principle for lung-targeted protein delivery. Leveraging this capability, we demonstrate that lung-targeted antigen delivery induces robust tissue-resident memory T cell responses within the pulmonary microenvironment and suppresses tumor growth in preclinical models of lung metastasis. Together, these findings redefine the in vivo functional role of phenylborate in nanocarrier systems and establish a versatile materials platform for lung-targeted protein therapeutics and site-specific immune modulation.
- 24 August 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (35) , 24401-24414
Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity
Effective lung-targeted therapies can directly treat pulmonary diseases and engage tissue-resident immunity for lasting effects. However, protein delivery systems specifically targeting the lung remain scarce. Here, we report the discovery of phenylborate (PBA)-functionalized polymeric nanocapsules that enable efficient pulmonary delivery of protein cargos following systemic administration. Systematic structure–activity relationship studies revealed that PBA incorporation strongly correlates with enhanced lung tropism, establishing a previously unrecognized materials design principle for lung-targeted protein delivery. Leveraging this capability, we demonstrate that lung-targeted antigen delivery induces robust tissue-resident memory T cell responses within the pulmonary microenvironment and suppresses tumor growth in preclinical models of lung metastasis. Together, these findings redefine the in vivo functional role of phenylborate in nanocarrier systems and establish a versatile materials platform for lung-targeted protein therapeutics and site-specific immune modulation.
- 26 March 2026
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 137, 118641
A multifunctional hydrogel for synergistic dendritic cell activation and immunogenic cell death induction in enhanced chemoimmunotherapy
- 26 March 2026
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 137, 118641
A multifunctional hydrogel for synergistic dendritic cell activation and immunogenic cell death induction in enhanced chemoimmunotherapy
- Open Access
- 18 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1961
CGL, a Lectin from Crenomytilus grayanus, Exhibits Antibiofilm and Synergistic Antibacterial Activity Against Escherichia coli and Staphylococcus aureus
Lectins are carbohydrate-binding proteins that specifically bind to sugar groups associated with other molecules. Several studies have reported that these proteins can also modulate the activity of antibiotics against multidrug-resistant (MDR) strains in addition to interacting with carbohydrates. This study reports that gentamicin exhibits enhanced antibacterial activity against Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive) bacterial strains when complexed with Crenomytilus grayanus lectin (CGL). Enzyme-linked lectin, thermofluor, and isothermal titration calorimetry assays revealed that gentamicin interacts with CGL through a domain distinct from the carbohydrate recognition domain. An increase in antibacterial activity was observed when lectin and antibiotic were used together against S. aureus in living systems—specifically, sea urchin (Strongylocentrotus nudus) embryos.
- 18 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1961
Open AccessCGL, a Lectin from Crenomytilus grayanus, Exhibits Antibiofilm and Synergistic Antibacterial Activity Against Escherichia coli and Staphylococcus aureus
Lectins are carbohydrate-binding proteins that specifically bind to sugar groups associated with other molecules. Several studies have reported that these proteins can also modulate the activity of antibiotics against multidrug-resistant (MDR) strains in addition to interacting with carbohydrates. This study reports that gentamicin exhibits enhanced antibacterial activity against Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive) bacterial strains when complexed with Crenomytilus grayanus lectin (CGL). Enzyme-linked lectin, thermofluor, and isothermal titration calorimetry assays revealed that gentamicin interacts with CGL through a domain distinct from the carbohydrate recognition domain. An increase in antibacterial activity was observed when lectin and antibiotic were used together against S. aureus in living systems—specifically, sea urchin (Strongylocentrotus nudus) embryos.
- Open Access
Microbial Selenium-Enriched Bacterial Fertilizer: Biofortification Technology to Boost Pea Sprout Quality and Selenium Content
Selenium-enriched vegetables are a safe way to combat selenium deficiency in humans. Here, a new microbial selenium-enriched bacterial fertilizer (named “HJ”) was prepared and studied by dipping, and then its application strategy was optimized and compared with other commercially available selenium fertilizers. The results showed that the application of HJ selenium fertilizer to peas by soaking (Se concentration 10 μg/mL) and foliar application (Se concentration 8 μg/mL) could effectively enhance their growth, selenium enrichment ability, stress tolerance and nutritional quality. In particular, the selenium content of peas in the HJ-treated group exhibited a significant increase of 69.86% in comparison with the control group. Moreover, HJ treated pea sprouts demonstrated enhanced antioxidant activity, as well as elevated levels of vitamin C and protein, amongst other observations. The findings of this study offer novel insights into the development of eco-friendly selenium fertilizers and provide guidance for optimal fertilizer application techniques.
Open AccessMicrobial Selenium-Enriched Bacterial Fertilizer: Biofortification Technology to Boost Pea Sprout Quality and Selenium Content
Selenium-enriched vegetables are a safe way to combat selenium deficiency in humans. Here, a new microbial selenium-enriched bacterial fertilizer (named “HJ”) was prepared and studied by dipping, and then its application strategy was optimized and compared with other commercially available selenium fertilizers. The results showed that the application of HJ selenium fertilizer to peas by soaking (Se concentration 10 μg/mL) and foliar application (Se concentration 8 μg/mL) could effectively enhance their growth, selenium enrichment ability, stress tolerance and nutritional quality. In particular, the selenium content of peas in the HJ-treated group exhibited a significant increase of 69.86% in comparison with the control group. Moreover, HJ treated pea sprouts demonstrated enhanced antioxidant activity, as well as elevated levels of vitamin C and protein, amongst other observations. The findings of this study offer novel insights into the development of eco-friendly selenium fertilizers and provide guidance for optimal fertilizer application techniques.
- Open Access
- 2 June 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (6) , 1136
Screening and Identification of Soil Selenium-Enriched Strains and Application in Auricularia auricula
Selenium (Se) is an essential trace element for human physiological metabolism. The application of organic Se as a source to cultivate Se-rich plants for micronutrient supplementation has been receiving increasing attention. In our study, a bacterial strain named H1 was isolated from the soil in Heilongjiang Province, China, and under optimal culture conditions, the unit Se content could reach 3000 μg·g−1 and its 16S ribosomal DNA sequence seemed to be a new molecular record of an Enterobacter species. After the domestication of Se tolerance and Se-rich experiments, H1 can be used as a Se source for cultivation of Se-rich Auricularia auricula. The results showed that soluble protein, soluble sugar, free amino acid and vitamin C contents in Auricularia auricula were notably increased by 28.7%, 21.8%, 32.5% and 39.2% under the treatment of Se concentration of 0.24 mg·kg−1, respectively. These findings enhance our understanding that H1 is more conducive to Se uptake and nutrient accumulation.
- 2 June 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (6) , 1136
Open AccessScreening and Identification of Soil Selenium-Enriched Strains and Application in Auricularia auricula
Selenium (Se) is an essential trace element for human physiological metabolism. The application of organic Se as a source to cultivate Se-rich plants for micronutrient supplementation has been receiving increasing attention. In our study, a bacterial strain named H1 was isolated from the soil in Heilongjiang Province, China, and under optimal culture conditions, the unit Se content could reach 3000 μg·g−1 and its 16S ribosomal DNA sequence seemed to be a new molecular record of an Enterobacter species. After the domestication of Se tolerance and Se-rich experiments, H1 can be used as a Se source for cultivation of Se-rich Auricularia auricula. The results showed that soluble protein, soluble sugar, free amino acid and vitamin C contents in Auricularia auricula were notably increased by 28.7%, 21.8%, 32.5% and 39.2% under the treatment of Se concentration of 0.24 mg·kg−1, respectively. These findings enhance our understanding that H1 is more conducive to Se uptake and nutrient accumulation.
- Open Access
- 2 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 972345
Research advance of natural products in tumor immunotherapy
Cancer immunotherapy has emerged as a novel anti-tumor treatment. Despite significant breakthroughs, cancer immunotherapy remains focused on several types of tumors that are sensitive to the immune system. Therefore, effective strategies to expand its indications and improve its efficacy become key factors for the further development of cancer immunotherapy. In recent decades, the anticancer activities of natural products are reported to have this effect on cancer immunotherapy. And the mechanism is largely attributed to the remodeling of the tumor immunosuppressive microenvironment. The compelling data highlight that natural products offer an alternative method option to improve immune function in the tumor microenvironment (TME). Currently, more attention is being paid to the discovery of new potential modulators of tumor immunotherapy from natural products. In this review, we describe current advances in employing natural products and natural small-molecule drugs targeting immune cells to avoid tumor immune escape, which may bring some insight for guiding tumor treatment.
- 2 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 972345
Open AccessResearch advance of natural products in tumor immunotherapy
Cancer immunotherapy has emerged as a novel anti-tumor treatment. Despite significant breakthroughs, cancer immunotherapy remains focused on several types of tumors that are sensitive to the immune system. Therefore, effective strategies to expand its indications and improve its efficacy become key factors for the further development of cancer immunotherapy. In recent decades, the anticancer activities of natural products are reported to have this effect on cancer immunotherapy. And the mechanism is largely attributed to the remodeling of the tumor immunosuppressive microenvironment. The compelling data highlight that natural products offer an alternative method option to improve immune function in the tumor microenvironment (TME). Currently, more attention is being paid to the discovery of new potential modulators of tumor immunotherapy from natural products. In this review, we describe current advances in employing natural products and natural small-molecule drugs targeting immune cells to avoid tumor immune escape, which may bring some insight for guiding tumor treatment.
- 16 May 2018
- Published by Tsinghua University Press in Nano Research
- Vol. 11 (10) , 5028-5048
In situ polymerization on biomacromolecules for nanomedicines
Biopharmaceuticals, including proteins, DNAs, and RNAs, hold vast promise for the treatment of many disorders, such as cancer, diabetes, autoimmune diseases, infectious diseases, and rare diseases. The application of biopharmaceuticals, however, is limited by their poor stability, immunogenicity, suboptimal pharmacokinetic performance, undesired tissue distribution, and low penetration through biological barriers. In situ polymerization provides an appealing and promising platform to improve the pharmacological characteristics of biopharmaceuticals. Instead of the traditional “grafting to” polymer–biomolecule conjugation, in situ polymerization grows polymers on the surfaces of the biomacromolecules, resulting in easier purification procedures, high conjugation yields, and unique structures. Herein, this review surveys recent advances in the polymerization methodologies. Additionally, we further review improved therapeutic performance of the resultant nanomedicines. Finally, the opportunities, as well as the challenges, of these nanocomposites in the biomedical fields are discussed. Open image in new window
- 16 May 2018
- Published by Tsinghua University Press in Nano Research
- Vol. 11 (10) , 5028-5048
In situ polymerization on biomacromolecules for nanomedicines
Biopharmaceuticals, including proteins, DNAs, and RNAs, hold vast promise for the treatment of many disorders, such as cancer, diabetes, autoimmune diseases, infectious diseases, and rare diseases. The application of biopharmaceuticals, however, is limited by their poor stability, immunogenicity, suboptimal pharmacokinetic performance, undesired tissue distribution, and low penetration through biological barriers. In situ polymerization provides an appealing and promising platform to improve the pharmacological characteristics of biopharmaceuticals. Instead of the traditional “grafting to” polymer–biomolecule conjugation, in situ polymerization grows polymers on the surfaces of the biomacromolecules, resulting in easier purification procedures, high conjugation yields, and unique structures. Herein, this review surveys recent advances in the polymerization methodologies. Additionally, we further review improved therapeutic performance of the resultant nanomedicines. Finally, the opportunities, as well as the challenges, of these nanocomposites in the biomedical fields are discussed. Open image in new window